0:00
/
0:00
Transcript

Disclosure: This is not a recommendation to buy a security. Always get professional financial advice. Investing in biotech stocks is risky with the potential for large non-recoverable losses.

InmuneBio ($INMB)

Everyone is talking about Jon Kulok’s InmuneBio write up. So we had to get him on YWR.

In Part 1 of the video Jon explains water soluble TNF’s and why ImmuneBio could eventually be a $2bn market cap company.

In Part 2 we speak to CEO RJ Tesi on the Stage 2 Trial and why ImmuneBio is on the path to curing some forms of Alzheimers.

Enjoy,

Erik

Discussion about this podcast